These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4017421)

  • 1. Losulazine, a new antihypertensive.
    Gore R; Musselman D; Micalizzi E; Slomka M
    Clin Pharmacol Ther; 1985 Aug; 38(2):195-8. PubMed ID: 4017421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Felodipine, a new calcium antagonist, as monotherapy in mild or moderate hypertension. Cooperative study group.
    Drugs; 1987; 34 Suppl 3():139-48. PubMed ID: 2894973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of losulazine hydrochloride, a peripheral norepinephrine-depleting agent, in nonhuman primates.
    Pals DT; DeGraaf GL
    J Pharmacol Exp Ther; 1985 Feb; 232(2):407-12. PubMed ID: 3968642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of urapidil and atenolol in hypertension.
    Török E; Wagner M; Podmaniczky M
    Drugs; 1988; 35 Suppl 6():164-72. PubMed ID: 3042356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up, noninferiority trial.
    Hong SJ; Ahn TH; Baek SH; Cho WH; Jeon HK; Kwan J; Yoon MH; Lee KJ; Lim DS
    Clin Ther; 2006 Apr; 28(4):537-51. PubMed ID: 16750465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of isosorbide in the treatment of severe, uncontrolled hypertension.
    Fontanet H; García JC; del Río J; Martínez-Maldonado M
    Arch Intern Med; 1987 Mar; 147(3):426-8. PubMed ID: 3827416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study.
    Jackson B; Morgan TO; Gibson J; Anderson A
    Drugs; 1987; 34 Suppl 3():109-19. PubMed ID: 2894971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial.
    Solomon SD; Janardhanan R; Verma A; Bourgoun M; Daley WL; Purkayastha D; Lacourcière Y; Hippler SE; Fields H; Naqvi TZ; Mulvagh SL; Arnold JM; Thomas JD; Zile MR; Aurigemma GP;
    Lancet; 2007 Jun; 369(9579):2079-87. PubMed ID: 17586303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic treatment with tibalosine in essential hypertension.
    Staessen J; Fagard R; Fiocchi R; Lijnen P; M'Buyamba-Kabangu JR; Amery A
    Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):162-76. PubMed ID: 3516092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive efficacy of urapidil versus hydrochlorothiazide alone in patients with mild to moderate essential hypertension and of their combination in nonresponders to monotherapy.
    Fariello R; Dal Palu C; Pessina A; Semplicini A; Pirrelli A; Vulpis V; Carretta R; Bellini G; Buoninconti R; Wurst W
    Drugs; 1990; 40 Suppl 4():60-2. PubMed ID: 2092970
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of isradipine in hypertension.
    Shepherd AM; Carr AA; Davidov M; Hamilton J; Schnaper H; Velasquez M; Brockway B; Prisant LM; Hamilton B; Gonasun L
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):580-5. PubMed ID: 2470995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Felodipine in hypertensive patients. A dose finding study in patients refractory to beta-blocker monotherapy.
    Sluiter HE
    Drugs; 1987; 34 Suppl 3():97-106. PubMed ID: 2894980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind comparison of trimazosin and propranolol in essential hypertension.
    Helgeland A
    Am Heart J; 1983 Nov; 106(5 Pt 2):1253-8. PubMed ID: 6356854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of urapidil, a new antihypertensive drug: preliminary findings in Japan.
    Taniguchi K; Nakamura S; Iesaka Y; Nitta M; Ito H; Kirigaya H; Takeuchi J; Fujiwara H; Iizumi T; Inada M
    Clin Ther; 1985; 7(5):559-67. PubMed ID: 4053145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monotherapy with felodipine, a new calcium antagonist, in mild and moderate hypertension.
    Hamilton DV; Barnes PC; Bowles RM; Rajaratnam DV; Comerford MB; Ginks WR; Ginks SE; Goves JR; Grabau WJ; Malcolm JP
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S111-3. PubMed ID: 2455107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new antihypertensive agent used in a clinical setting].
    Wetzels E; Raschig A; Kaiser HJ
    Med Klin; 1980 Sep; 75(19):688-92. PubMed ID: 7001207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of once-daily urapidil treatment in mild or moderate essential hypertension assessed by ambulatory 24-hour blood pressure monitoring.
    Trimarco B; Rosiello G; Feldhaus P; Steinijans VW; Vecchione F; Cuocolo A; Lembo G; Volpe M
    Drugs; 1988; 35 Suppl 6():173-81. PubMed ID: 3402355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.